DSM Purchases Patent for Catalyst from University of Amsterdam

DSM, a global science-based company active in materials, nutrition and health, has signed a transfer agreement with the University of Amsterdam to purchase the patent and all the associated Intellectual Property (IP) rights for a new catalyst.

The agreement also comprises a five year joint project to advance the catalyst technology for use in DSM’s production operations.

The catalyst has been developed by Dr. Raveendran Shiju, a scientist at the University’s Van 't Hoff Institute for Molecular Sciences. The technology contributes to eco-friendly, green developments by considerably minimizing the amount of catalyst generated. The novel catalyst is ideal for sustainable or green industrial processes to produce fine chemicals, pharmaceutical intermediates and polymers.

Prof. Gadi Rothenberg, who leads the Heterogeneous Catalysis and Sustainable Chemistry group at the University of Amsterdam, stated that along with DSM, the novel catalyst will be tested on a pilot scale. DSM expects that the partnership with the University will help to enhance the efficiency of its operations and to increase opportunities for application development and market entry.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). DSM Purchases Patent for Catalyst from University of Amsterdam. AZoM. Retrieved on November 24, 2024 from https://www.azom.com/news.aspx?newsID=32162.

  • MLA

    Chai, Cameron. "DSM Purchases Patent for Catalyst from University of Amsterdam". AZoM. 24 November 2024. <https://www.azom.com/news.aspx?newsID=32162>.

  • Chicago

    Chai, Cameron. "DSM Purchases Patent for Catalyst from University of Amsterdam". AZoM. https://www.azom.com/news.aspx?newsID=32162. (accessed November 24, 2024).

  • Harvard

    Chai, Cameron. 2019. DSM Purchases Patent for Catalyst from University of Amsterdam. AZoM, viewed 24 November 2024, https://www.azom.com/news.aspx?newsID=32162.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.